Industry

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. MARKET OUTLOOK This report states that the Alzheimer’s disease therapeutics and diagnostics market in the Asia-Pacific would fast progress with a CAGR of 12.18% over the forecast duration from 2022 to 2028. Japan, India, South Korea, China, Australia … [Read more…]

CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine The Omicron BA.1-adapted bivalent COVID-19 vaccine combines 15-µg of mRNA encoding the SARS-CoV-2 wild-type spike protein which is in the Original Pfizer-BioNTech COVID-19 Vaccine with 15-µg of mRNA encoding the spike protein of the Omicron … [Read more…]

As Flu Season Approaches and COVID-19 Continues to Spread Throughout the U.S., GenBody America Updates Their Test Kits to Include Individual Reagent Bottles — Significantly Enhancing Ease of Testing JURUPA VALLEY, Calif.–(BUSINESS WIRE)–#AntigenTestKits—GenBody America, LLC, the U.S. affiliate of GenBody, Inc., a South Korean manufacturer of rapid diagnostic tests and reagents for point-of-care applications for … [Read more…]

New silicon-based drugs made with Fuzionaire’s proprietary alkali metal catalyst platform could offer improved efficacy and reduced toxicity THE WOODLANDS, Texas–(BUSINESS WIRE)–Fuzionaire, Inc. today announced a collaborative research agreement with McGill University that will leverage the company’s proprietary alkali metal catalyst platform in creating novel heterocyclic, biologically active, silicon-containing scaffolds and new silicon-based drug candidates. … [Read more…]

This recognition is a testament to HARMAN DTS’s capabilities to design, develop and deliver best-in-class products and solutions at speed and scale. STAMFORD, Conn.–(BUSINESS WIRE)–HARMAN, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. focused on connected technologies for automotive, consumer and enterprise markets, is honored to announce that its Digital Transformation Solutions (DTS) business unit … [Read more…]

The $1.18M raised during the 2022 Climb to Cure campaign brings lender nearly halfway to $10M by 2025 goal ATLANTA–(BUSINESS WIRE)–Lendmark Financial Services, a leading provider of household credit and consumer loan solutions, has raised the bar for itself and launched a bold new campaign and goal: to raise $10 million total by 2025 to … [Read more…]

Transition to new brand now complete across 350 locations in 38 states LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) has announced the completion of its initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. With today’s announcement, CenterWell Home Health is now the official name for the more than … [Read more…]

Dr. Baxi will help shape the company’s scientific roadmap and support its vision of building technological solutions to improve patient outcomes CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that Shrujal Baxi, MD, MPH, has joined its leadership team as Chief Medical Officer. “Having a stellar scientific, medical, and regulatory … [Read more…]

LONDON–(BUSINESS WIRE)–#ElectricalServices–H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that one of its affiliates has acquired CPS Building Services Limited (“CPS” or the “Company”), a leading UK provider of mechanical and electrical (M&E) services, from its founder. CPS’ current MD, … [Read more…]

Immusoft makes history with the first engineered B cell investigational therapy cleared for human trials Immusoft seeks to improve the treatment of MPS I, a rare childhood disease, through the use of its Immune System Programming (ISP™) approach that utilizes B cells as re-dosable biofactories for therapeutic protein delivery The company has received FDA Orphan … [Read more…]